A founder

Alport syndrome COL4A3 consanguinity founder effect thin basement membrane disease

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2023
Historique:
received: 21 08 2023
accepted: 05 12 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

Alport syndrome is a rare genetic condition characterized by kidney disease, hearing impairment, and ocular abnormalities. It exhibits various inheritance patterns involving pathogenic variants in

Identifiants

pubmed: 38188341
doi: 10.3389/fmed.2023.1281049
pmc: PMC10768050
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1281049

Informations de copyright

Copyright © 2023 Tkemaladze, Bregvadze, Kvaratskhelia, Abzianidze and Davitaia.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Tinatin Tkemaladze (T)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.
Department of Pediatrics, Givi Zhvania Pediatric Academic Clinic, Tbilisi State Medical University, Tbilisi, Georgia.

Kakha Bregvadze (K)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Eka Kvaratskhelia (E)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Elene Abzianidze (E)

Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.

Tinatin Davitaia (T)

Department of Pediatrics, Givi Zhvania Pediatric Academic Clinic, Tbilisi State Medical University, Tbilisi, Georgia.

Classifications MeSH